Four Ways to Talk to Your Employees Now About COVID-19 Vaccines

15 December 2020 Coronavirus Resource Center:Back to Business Blog

One of the most pressing questions regarding COVID-19 vaccines is whether employers may require employees to be vaccinated. Employees are understandably anxious and employers have not yet received much information from the government on potential guidance regulating vaccines in the workplace.  

Here are four ways to discuss COVID-19 vaccinations in the workplace now, before the vaccines are more widely distributed to the public in 2021.

1. Educate your workforce on the COVID-19 vaccines. The amount of conflicting information on COVID-19 vaccines is staggering.  Take the time to send out vetted facts to employees from the FDA and official sources.  Encourage employees to speak to physicians about concerns. 

2. Slow Down.  The COVID-19 vaccine is not currently available to the general public and will not be widely available for several months.   Take the time to calm down employees, while being sympathetic to their concerns.  Talk about fears and issues surrounding the refusal to take a COVID-19 vaccine. If your company has an EAP program, distribute information regularly. 

3. Recognize exceptions to mandatory vaccines.  Even if you are considering a requirement that employees be vaccinated, it is important to remember that many individuals may not be subject to a mandatory vaccine policy.  For example, persons with disabilities under the Americans with Disabilities Act may be exempt from vaccination requirements. Therefore, it is important for companies to engage in the interactive process early to determine whether reasonable accommodations are necessary.  And some employees may be exempt for religious purposes. 

4. Executives should start discussing the ramifications of mandatory COVID-19 vaccines.  Employees want to know now if the COVID-19 vaccine will be mandatory, but before the company issues a policy, several considerations exist, such as:

  • Will the company pay for the vaccine? 
  • If employees refuse to take the vaccine, will they be fired? 
  • Will employees refusing to take the vaccine be allowed to work at home while others are required to come to work? 
  • If employees have reactions or side effects, will the company compensate them for time off to recover? 

Right now, employees and companies are hyper-focused on how to resume their prior activities.  With a little planning and communication before the vaccines are widely distributed, companies can help ease the transition back to work.

For additional information on this, please contact the article author, Rachel Powitzky Steely.

Companies in all sectors of the economy continue to be impacted by COVID-19. Foley is here to help our clients effectively address the short- and long-term impacts on their business interests, operations, and objectives. Foley provides insights and strategies across multiple industries and disciplines to deliver timely perspectives on the wide range of legal and business challenges that companies face conducting business while dealing with the impact of the coronavirus. Click here to stay up to date and ahead of the curve with our key publications addressing today’s challenges and tomorrow’s opportunities. To receive this content directly in your inbox, click here and submit the form.

 
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Insights

30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream